RVL Pharmaceuticals PLC (NASDAQ:RVLP)
| 0.1233 BATS BZX Real-Time Price As of 2:38pm ET |  -0.0053 / -4.12%Today’s Change | 0.08 Today|||52-Week Range 2.42 | -88.99% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 66.3M | 65.7M | 57.1M | 57.5M | |
| Cost of Goods Sold | 12.0M | 15.9M | 11.7M | 15.2M | ||
| Depreciation And Amortization | 20.5M | 20.2M | 18.0M | 18.0M | ||
| Operating Expenses | Gross Income | 33.9M | 29.6M | 27.4M | 24.4M | |
| General Expenses | 30.3M | 39.0M | 30.9M | 30.4M | ||
| Research And Development | 13.3M | 16.3M | 9.8M | 5.4M | ||
| Total Operating Expenses | 62.8M | 75.1M | 60.6M | 63.5M | ||
| Non-Operating Expenses | Operating Income | 3.6M | -9.4M | -3.5M | -6.0M | |
| Extraordinary Charge | -6.2M | -98.0M | 0.00 | -125.8M | ||
| Interest Expense On Debt | 5.3M | 5.4M | 4.5M | 4.6M | ||
| Other Expenses | 434.1K | -216.3K | 557.0K | -14.7K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -7.5M | -113.1M | -7.4M | -136.3M | |
| Income Taxes | -2.5M | -5.8M | -1.2M | -11.7M | ||
| Net Income | -5.0M | -107.2M | -6.2M | -124.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 52.5M | 52.5M | 52.5M | 52.5M | |
| Shares To Calculate EPS Diluted | 52.5M | 52.5M | 52.5M | 52.5M | ||
| Earnings Per Share | EPS | -$0.10 | -$2.04 | -$0.12 | -$2.37 | |
| EPS Diluted | -$0.10 | -$2.04 | -$0.12 | -$2.37 | ||
